ENGENE THERAPEUTICS INC.
Last · NASDAQ$1.82-0.01 (-0.55%)stale · yahoo · 93h ago
MA10MA20MA50
Market cap$121.92M67.0M sh
P/E · TTM-0.8fwd -1.3 · eps -2.18 · loss
Beta-0.27vs S&P 500
Div yield—annual · TTM
52w range
$1.40$12.25
Volume412.7Ksession
Issuer
Legal nameENGENE THERAPEUTICS INC.
HQUnited States (US)
ListingUS ENGN
ISINCA29286X1015
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001980845
CIK0001980845
Websitewww.engene.com
Employees82
AddressenGene Holdings, Inc. 4868 Rue Levy H4R 2P1, Saint-Laurent
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2025-12-22
From latest 10-K · 2025-12-22
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.5 years
- Accumulated Deficit High — Accumulated deficit / equity 222%
Earnings
TUE.8SEP
Reported · 1:30 PM UTC+2
Period
Jun 2026
EPS
−$0.47Missed−9.3%
Est. revenue
—
MON.14SEP
2:30 PM UTC+2
Period
Jul 2026
Est. EPS
−$0.43
Est. revenue
0
Documents
FormReporting forFiledFlags
Showing 5 of 91 filings